Quick links
Our courses
Sorry, we couldn't find any courses that match your search. Try searching for something else.
Our research
Search our website
Popular searches
Your search term has returned 0 results
Research Development Assistant
Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients
Haque, F., Ryde, J., Broughton, L., Huang, C., Sethi, S., Stephens, A., …Maraveyas, A. (2023). Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients. ERJ Open Research, 9(3), Article 00651-2022. https://doi.org/10.1183/23120541.00651-2022
Duramycin-porphyrin conjugates for targeting of tumour cells using photodynamic therapy
Broughton, L. J., Giuntini, F., Savoie, H., Bryden, F., Boyle, R. W., Maraveyas, A., & Madden, L. A. (2016). Duramycin-porphyrin conjugates for targeting of tumour cells using photodynamic therapy. Journal of photochemistry and photobiology. B, Biology, 163, 374-384. https://doi.org/10.1016/j.jphotobiol.2016.09.001
Duramycin-induced calcium release in cancer cells
Broughton, L. J., Crow, C., Madden, L. A., & Maraveyas, A. (2016). Duramycin-induced calcium release in cancer cells. Anti-cancer drugs, 27(3), 173-182. https://doi.org/10.1097/cad.0000000000000313
Targeting phosphatidylethanolamine on tumour cells using duramycin
Broughton, L. (2014). Targeting phosphatidylethanolamine on tumour cells using duramycin. Thrombosis Research, 133(Supplement 2), S213-S213. https://doi.org/10.1016/s0049-3848%2814%2950032-1
Project
Funder
Grant
Started
Status
Hull University Teaching Hospitals NHS Trust
£89,343.00
1 September 2024
Ongoing
£65,651.00
1 January 2023
Complete
£57,691.00
Centre for Clinical Sciences
Browser does not support script.